Resultados: 19

    Therapeutics and COVID-19: living guideline - 16 September 2022

    The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...

    COVID-19 rapid guideline: managing COVID-19. Last updated: 14 July 2022

    This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use ...

    Guía práctica clínica para el manejo de COVID-19 en niños

    El tratamiento oportuno de personas con COVID-19 busca minimizar el número de complicaciones y muertes por esta enfermedad. Por ello, el Seguro Social de Salud del Perú (EsSalud) priorizó la realización de la presente guía de práctica clínica (GPC) con la finalidad de establecer recomendaciones ba...

    Guía práctica clínica: prevención y manejo de COVID-19 en adultos - 3 ed

    El tratamiento oportuno de personas con COVID-19 busca minimizar el número de complicaciones y muertes por esta enfermedad. Por ello, el Seguro Social de Salud del Perú (EsSalud) priorizó la realización de la presente guía de práctica clínica (GPC) con la finalidad de establecer recomendaciones ba...

    American Society of Transplantation and Cellular Therapy series 4: Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation

    The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A new...

    American Society for Transplantation and Cellular Therapy series: 3: Prevention of Cytomegalovirus infection and disease after Hematopoietic Cell Transplantation

    Transplant cell ther; 27 (9), 2021
    The Practice Guidelines Committee of the American Society for Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to update its 2009 compendium-style infectious diseases guidelines for the care of hematopoietic cell transplant (HCT) recipients. A n...

    Prevención de la transmisión maternoinfantil del virus de la hepatitis B. directrices sobre la profilaxis con antivirales en el embarazo

    Según estimaciones de la Organización Mundial de la Salud (OMS), en el 2015 257 millones de personas en el mundo tenían la infección crónica por el virus de la hepatitis B (VHB) y 900 000 fallecieron a causa de ella, en la mayor parte de los casos de cirrosis o carcinoma hepatocelular. La mayoría d...

    Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline

    Eur. respir. j; 57 (4), 2021
    Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of SARS-CoV-2 infection have a high mortality rate and frequently require noninvasive respiratory support or invasive ventilation. Optimising and standardising management through evidence-based guidelines may improve quality of ca...

    Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines

    Pharmacol. res; 160 (), 2020
    Influenza is a major public health problem worldwide. Mutations and resistance development make the use of antiviral therapy challenging. Chinese patent medicines are often used to treat influenza in China and well tolerable. However, the misuse of Chinese patent medicines is common. We therefore aimed t...

    Remdesivir for severe COVID-19: a clinical practice guideline

    BMJ; 370 (), 2020
    Clinical question: What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. Aft...